U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07855029) titled 'Impact of Functional Cure of Chronic Hepatitis B on Patient-Reported Outcomes (PROs)' on Sept. 21.

Brief Summary: This single-center comparative cross-sectional study includes a prospective longitudinal follow-up cohort. At least 400 subjects from the "Everest Project" cohort will be enrolled into four groups: clinical-cure, non-cure, relapse, and healthy control. Data will be collected via online/offline questionnaires with internationally-standardized scales. This study aims to first systematically characterize the psychosocial value of chronic hepatitis B clinical cure, advance the shift from biomedical to biopsychosocial holistic...